Welcome to our dedicated page for Verisign SEC filings (Ticker: VRSN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The VeriSign, Inc. (VRSN) SEC filings page on Stock Titan brings together the company’s regulatory disclosures, including Form 8‑K current reports and other registered offerings referenced in its communications. Verisign is a Delaware corporation listed on NASDAQ, and its filings identify it under Commission File Number 000-23593 and IRS Employer Identification Number 94-3221585.
Verisign uses Form 8‑K to report a variety of material events. Recent 8‑K filings include items on results of operations and financial condition, where the company furnishes earnings press releases for quarters ended June 30 and September 30, and clarifies that these materials are not deemed “filed” for certain Exchange Act purposes unless specifically incorporated by reference. Other 8‑K items address Board and executive matters, such as the appointment of a new director, director compensation and indemnity agreements, and the resignation of a long‑serving director, along with the Board’s intention to appoint a Lead Independent Director and adjust its size.
Verisign also files 8‑Ks under Item 8.01 Other Events to describe capital markets transactions and corporate actions. One filing details an underwriting agreement for a secondary offering of common stock by selling stockholders affiliated with Berkshire Hathaway Inc., noting that Verisign itself is not selling shares and will not receive proceeds. Another 8‑K describes additional authorization under the company’s share repurchase program, including the total repurchase authorization and the types of transactions through which repurchases may be executed.
For investors analyzing VRSN, this page provides near real‑time access to such 8‑K filings as they appear on EDGAR. Stock Titan’s tools can surface the key points in these documents, helping users quickly understand new earnings releases, Board changes, capital allocation decisions, and capital markets activities without reading every line of the underlying forms.
Verisign executive Thomas C. Indelicarto, EVP, General Counsel & Secretary, reported an open-market sale of 498 shares of Verisign common stock at $250.00 per share on March 25, 2026. After this transaction, he directly holds 39,198.258 Verisign shares, indicating this was a relatively small sale compared to his remaining stake.
Armstrong Courtney D reported open-market purchase transactions in this Form 4 filing.
VERISIGN INC/CA director Courtney D. Armstrong reported a small increase in his holdings. A trust associated with him, The Armstrong Family Trust, acquired 15.909 shares of common stock at $250.17 per share through the reinvestment of dividends.
Following this dividend reinvestment, Armstrong’s indirect ownership stands at 5,203.471 shares held by the trust, and he also holds 882.244 shares directly. This filing reflects a routine, incremental increase in his overall position rather than a large discretionary trade.
VeriSign, Inc. affiliate Thomas C. Indelicarto filed Form 144 reporting proposed sales of Common shares, with multiple transactions listed in early 2026. The excerpt shows several sales (for example, 332 shares for $79,885.84 on 03/10/2026 and 498 shares for $115,426.44 on 03/03/2026). Shares outstanding were 91,700,000 as of 03/25/2026; this is a baseline figure, not the amount being offered.
Verisign EVP, General Counsel & Secretary Thomas C. Indelicarto sold 332 shares of Verisign common stock in an open-market transaction on March 10, 2026 at $240.62 per share. After this sale, he directly owns 39,696.258 shares of Verisign common stock.
VeriSign reports insider sale notices filed on Form 144. The excerpt lists multiple sales by Thomas C. Indelicarto: $115,426.44 for 498 shares on 03/03/2026, $124,041.84 for 498 shares on 02/03/2026, and other sales in January and February 2026 (including 166 and 332 share tranches). The filing also lists 332 performance shares associated with 02/05/2026.
Verisign executive Thomas C. Indelicarto reported open-market sales of company stock. On March 3, 2026, he sold 332 shares of Verisign common stock at $235.00 per share and 166 shares at $225.34 per share, totaling 498 shares.
After these transactions, his directly held Verisign common stock stood at 40,028.258 shares. This amount includes 76.4472 dividend equivalent restricted stock units acquired on February 27, 2026 in respect of previously granted restricted stock units under the company’s equity incentive plan.
VRSN reports a proposed resale of 498 common shares via Form 144, dated 02/05/2026. The filing lists the securities as Performance Shares and shows multiple recent dispositions by Thomas C. Indelicarto, including sales on 02/03/2026 (498 shares, $124,041.84) and 02/10/2026 (166 shares, $36,393.84).
Verisign director Courtney D. Armstrong reported two open-market purchases of Verisign common stock. One transaction was an indirect purchase of 18.787 shares at $223.54 per share held by The Armstrong Family Trust, and the other was a direct purchase of 3.244 shares at $219.44 per share.
CALYS JOHN reported disposition transactions in a Form 4 filing for VRSN. The filing lists transactions totaling 308 shares at a weighted average price of $219.03 per share. Following the reported transactions, holdings were 32,248 shares.
Verisign executive Thomas C. Indelicarto, EVP, General Counsel & Secretary, reported multiple transactions in Verisign common stock dated February 15, 2026. Each transaction is coded “F,” meaning a tax-withholding disposition to cover tax liabilities upon vesting of restricted stock units under Rule 16b-3. One transaction involved 947.165 shares at $219.03 per share, after which he directly owned 40,449.8108 shares of Verisign common stock.